Insmed (INSM) Misses Q3 EPS by 7c ; Offers Guidance
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $126.29 -0.31%
Revenue Growth %: +253.1%
Financial Fact:
Investment income: 138K
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: +253.1%
Financial Fact:
Investment income: 138K
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q3 EPS of ($1.27), $0.07 worse than the analyst estimate of ($1.20). Revenue for the quarter came in at $93.42 million versus the consensus estimate of $93.35 million.
GUIDANCE:
Insmed sees FY2024 revenue of $340-360 million, versus the consensus of $357.1 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- ADARx Pharmaceuticals files for proposed IPO
- Barclays Upgrades ASOS Plc. (ASC:LN) (ASOMY) to Equalweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
